NOVABAY PHARMACEUTICALS INC (NBY)

US66987P3001 - Common Stock

0.1112  -0.03 (-20%)

Premarket: 0.1072 0 (-3.6%)

News Image
14 hours ago - Chartmill

Which stocks are moving on Wednesday?

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

News Image
17 hours ago - Chartmill

Top movers in Wednesday's session

Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

News Image
19 hours ago - Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

News Image
a day ago - InvestorPlace

NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023

NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image
2 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

News Image
7 months ago - Seeking Alpha

NovaBay stock soars 86% on optic allograft product deal (NYSE:NBY)

NovaBay (NBY) shares shot up 86% in early trading Monday after the biotech company announced it had signed a deal to commercialize BioStem Amniotic Tissue Allograft. Read more here.

News Image
9 months ago - NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Reports Record Avenova Sales Day